Artificial Super Neutrophils for Inflammation Targeting and HClO Generation against Tumors and Infections

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 31(2019), 19 vom: 20. Mai, Seite e1901179
1. Verfasser: Zhang, Chi (VerfasserIn)
Weitere Verfasser: Zhang, Lu, Wu, Wei, Gao, Fan, Li, Run-Qing, Song, Wen, Zhuang, Ze-Nan, Liu, Chuan-Jun, Zhang, Xian-Zheng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article HClO antibiosis antitumor biomimetic materials neutrophils Anti-Inflammatory Agents Antineoplastic Agents Enzymes, Immobilized Membranes, Artificial mehr... Zeolites 1318-02-1 Hypochlorous Acid 712K4CDC10 Glucose Oxidase EC 1.1.3.4 Chloride Peroxidase EC 1.11.1.10
Beschreibung
Zusammenfassung:© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Neutrophils are powerful effector leukocytes that play an important role in innate immune systems for opposing tumor progression and ameliorating pathogen infections. Inspired by their distinct functions against tumors and infections, the artificial "super neutrophils" are proposed with excellent inflammation targeting and hypochlorous acid (HClO) generation characteristics for targeting and eliminating malignant tumor cells and pathogens. The "super neutrophils" are fabricated by embedding glucose oxidase (GOx) and chloroperoxidase (CPO) into zeolitic imidazolate framework-8 (ZIF-8) for HClO generation via enzymatic cascades, and then encapsulating them with the neutrophil membrane (NM) for inflammation targeting. In vitro and in vivo results indicate that these artificial "super neutrophils" can generate seven times higher reactive HClO than the natural neutrophils for eradicating tumors and infections. The "super neutrophils" demonstrated here with easy fabrication and good neutrophil-mimicking property exhibit great potential for biomedical applications
Beschreibung:Date Completed 27.11.2019
Date Revised 30.09.2020
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.201901179